CAI Q2 2019 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M-0.1% YoY

Gross Profit

$51M48.1% margin

Operating Income

$34M32.6% margin

Net Income

$9M8.8% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

$61M

Free Cash Flow

$35M

Stock-Based Comp.

$562,000

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$692M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$106M	-0.1%
Gross Profit	$51M	$52M	-2.2%
Operating Income	$34M	$37M	-7.5%
Net Income	$9M	$20M	-54.0%